The global radiotherapy devices market is expected to decline from $5.75 billion in 2019 to $5.44 billion in 2020 at a compound annual growth rate (CAGR) of -5.35%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities.
Read »
|